A novel complement-inhibitor gene therapy showed reasonable safety and tolerability in a phase-one clinical trial for geographic atrophy from AMD

Patients with Retinitis Pigmentosa have significantly higher rates of depression compared to the general population

A study of Chicagoland children demonstrated increased rates of myopia progression during the COVID-19 pandemic, perhaps due to increased time spent on screens and indoors.